NORTH CHICAGO, Ill., Sept. 7, 2018 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.96 per share.
The cash dividend is payable Nov. 15, 2018 to stockholders of record at the close of business on Oct. 15, 2018.
Since the company's inception in 2013, AbbVie has increased its dividend by 140 percent. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.
AbbVie is a global, research and development-based biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook or LinkedIn.
View original content:http://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-300708843.html
Media, Adelle Infante, (847) 938-8745, email@example.com; Investors, Liz Shea, (847) 935-2211, firstname.lastname@example.org